Publication | Closed Access

Axitinib plus gemcitabine versus placebo plus gemcitabine in patients with advanced pancreatic adenocarcinoma: a double-blind randomised phase 3 study

Gemcitabine Versus PlaceboOncologyPancreatic CancerGastrointestinal OncologyPharmacologyPharmacotherapyCancer TreatmentMedicineCancer ResearchAdvanced Pancreatic Adenocarcinoma